Joachim Sieper
Impact in
- Rheumatology top 0.01%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 0.05%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 493
- Spondyloarthritis Studies and Treatments 462
- Rheumatoid Arthritis Research and Therapies 200
- Systemic Lupus Erythematosus Research 24
- Immunology 115
- Psoriasis: Treatment and Pathogenesis 91
- Co-authors
- Jürgen Braun (178 shared papers)Martín Rudwaleit (166 shared papers)Joachim Listing (89 shared papers)Désirée van der Heijde (83 shared papers)Denis Poddubnyy (123 shared papers)Xenofon Baraliakos (66 shared papers)Hildrun Haibel (90 shared papers)J. Brandt (34 shared papers)
- Journals
- Annals of the Rheumatic Diseases (166 papers)Lara D. Veeken (35 papers)Arthritis Research & Therapy (24 papers)The Journal of Rheumatology (20 papers)RMD Open (19 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Joachim Sieper
532 papers receiving 36.9k citations
Joachim Sieper's Hit Papers
Peers
Comparison fields: 5 of 143
- Rheumatology 31.4k
- Hematology 6.2k
- Immunology 10.8k
- Orthopedics and Sports Medicine 2.4k
- Dermatology 642
Countries citing papers authored by Joachim Sieper
This map shows the geographic impact of Joachim Sieper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Sieper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Sieper more than expected).
Fields of papers citing papers by Joachim Sieper
This network shows the impact of papers produced by Joachim Sieper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Sieper. The network helps show where Joachim Sieper may publish in the future.
Co-authors
The 25 scholars most cited alongside Joachim Sieper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 552 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ankylosing spondylitis Hit paper breakdown → | 2007 | 1400 |
| 2 | The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis Hit paper breakdown → | 2009 | 1177 |
| 3 | The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general Hit paper breakdown → | 2010 | 1149 |
| 4 | Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial Hit paper breakdown → | 2002 | 960 |
| 5 | Axial spondyloarthritis Hit paper breakdown → | 2017 | 912 |
| 6 | Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis Hit paper breakdown → | 2015 | 748 |
| 7 | Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis Hit paper breakdown → | 2008 | 734 |
| 8 | Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors Hit paper breakdown → | 1998 | 701 |
| 9 | Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial Hit paper breakdown → | 2006 | 665 |
| 10 | Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT) Hit paper breakdown → | 2005 | 658 |
| 11 | Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group Hit paper breakdown → | 2009 | 656 |
| 12 | The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort Hit paper breakdown → | 2009 | 519 |
| 13 | 2002 | 472 | |
| 14 | ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis Hit paper breakdown → | 2008 | 458 |
| 15 | Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial Hit paper breakdown → | 2008 | 448 |
| 16 | New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS) Hit paper breakdown → | 2009 | 438 |
| 17 | 2006 | 395 | |
| 18 | Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1) Hit paper breakdown → | 2012 | 375 |
| 19 | 2003 | 360 | |
| 20 | 2005 | 360 |
About Joachim Sieper
Joachim Sieper is a scholar working on Rheumatology, Immunology, Hematology, Orthopedics and Sports Medicine and Pathology and Forensic Medicine, having authored 552 papers that have together received 38.1k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (462 papers), Rheumatoid Arthritis Research and Therapies (200 papers), Psoriasis: Treatment and Pathogenesis (91 papers), Autoimmune and Inflammatory Disorders Research (54 papers), Bone and Joint Diseases (36 papers), Systemic Lupus Erythematosus Research (24 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (13 papers) and Inflammatory mediators and NSAID effects (12 papers). The work is most often cited by research in Rheumatology (31.4k citations), Hematology (6.2k citations), Immunology (10.8k citations), Orthopedics and Sports Medicine (2.4k citations) and Dermatology (642 citations). Joachim Sieper has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Jürgen Braun, Martín Rudwaleit, Joachim Listing, Désirée van der Heijde, Denis Poddubnyy, Xenofon Baraliakos, Hildrun Haibel, J. Brandt, Maxime Dougados and Walter P. Maksymowych. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Arthritis Research & Therapy, The Journal of Rheumatology and RMD Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.